Laminar distribution of the pathological changes in frontal and temporal cortex in 8 patients with progressive supranuclear palsy

Clinical Neuropathology

Volumn 28, Issue 5, 2009, Pages 350-357

  Armstrong, R A ^a   Cairns, N J ^b  

^a ASTON UNIVERSITY   (United Kingdom)

^b WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

4R tauopathy; Frontal and temporal cortex; Laminar distribution; Neurofibrillary tangles (NFT); Progressive supranuclear palsy (PSP); Tufted astrocytes (TA)

Indexed keywords

TAU PROTEIN; MAPT PROTEIN, HUMAN;

ADULT; AGED; ARTICLE; ASTROCYTE; BRAIN REGION; CELL DENSITY; CELL INCLUSION; CELL NUCLEUS; CELL SURVIVAL; CELLULAR DISTRIBUTION; CLINICAL ARTICLE; FEMALE; FRONTAL CORTEX; GLIA CELL; HUMAN; HUMAN CELL; HUMAN TISSUE; MALE; NERVE CELL; NEUROFIBRILLARY TANGLE; NEUROPATHOLOGY; PRIORITY JOURNAL; PROGRESSIVE SUPRANUCLEAR PALSY; TEMPORAL CORTEX; THALAMUS INTRALAMINAR NUCLEUS; CELL COUNT; CELL SIZE; CYTOLOGY; DISEASE COURSE; FRONTAL LOBE; GLIA; METABOLISM; MIDDLE AGED; PATHOLOGY; SENILE PLAQUE; TEMPORAL LOBE;

AGED; AGED, 80 AND OVER; ASTROCYTES; CELL COUNT; CELL SIZE; CELL SURVIVAL; DISEASE PROGRESSION; FEMALE; FRONTAL LOBE; HUMANS; MALE; MIDDLE AGED; NEUROFIBRILLARY TANGLES; NEUROGLIA; NEURONS; SENILE PLAQUES; SUPRANUCLEAR PALSY, PROGRESSIVE; TAU PROTEINS; TEMPORAL LOBE;

EID: 70350044737     PISSN: 07225091     EISSN: None     Source Type: Journal    
DOI: 10.2379/NP300155     Document Type: Article

References (39)

1. Arima K, Nakamura M, Sunohara N, Nishio T, Ogawa M, Hirai S, Kawai M, Ikeda K. Immunohistochemical and ultrastructural characterization of neuritic clusters around ghost tangles in the hippocampal formation in progressive supranuclear palsy. Acta Neuropathol. 1999; 97: 565-576.
2. Armstrong RA. β-amyloid (Aβ) deposits and blood vessels: laminar distribution in the frontal cortex of patients with Alzheimer's disease. Neurosci Res Commun. 1996; 18: 19-28.
3. Armstrong RA, Slaven A. Does the neurodegeneration of Alzheimer's disease spread between visual cortical regions B17 and B18 via the feedforward or feedback short cortico-cortical projections? Neurodegen. 1994; 3: 191-196.
4. Armstrong RA, Cairns NJ, Lantos PL. Laminar distribution of cortical Lewy bodies and neurofibrillary tangles in dementia with Lewy bodies. Neurosci Res Commun. 1997; 21: 145-152.
5. Armstrong RA, Cairns NJ, Lantos PL. Laminar distribution of Pick bodies, Pick cells, and Alzheimer's disease pathology in the frontal and temporal cortex in Pick's disease. Neuropathol Appl Neurobiol. 1999; 25: 266-271.
6. Armstrong RA, Lantos PL, Cairns NJ. Laminar distribution of ballooned neurons and tau positive neurons with inclusions in patients with corticobasal degeneration. Neurosci Res Commun. 2000; 27: 85-93.
7. Armstrong RA, Lantos PL, Cairns NJ. Multiple system atrophy: laminar distribution of the pathological changes in frontal and temporal neocortex. Clin Neuropathol. 2005; 24: 230-235.
8. Armstrong RA, Lantos PL, Cairns NJ. Progressive supranuclear palsy (PSP: a quantitative study of the pathological changes in cortical and subcortical regions of eight cases. J Neural Transm. 2007; 114: 1569-1577.
9. Braak H, Braak E, Bohl J. Staging of Alzheimer-related cortical destruction. Eur Neurol. 1993; 33: 403-408.
10. Cairns NJ, Lee VM-Y, Trojanowski JQ. The cytoskeleton in neurodegenerative disease. J Pathol. 2004; 204: 438-449.
11. Conrad C, Andreadis A, Trojanwski JQ, Dickson DW, Kang D, Xiaxhua C, Wiederholt W, Hansen L, Masliah E, Thal LJ, Katzman R, Xia Y, Saitoh T. Genetic evidence for the involvement of tau in progressive supranuclear palsy. Ann Neurol. 1997; 41: 277-281.
12. Cordata NJ, Duggins AJ, Halliday GM, Morris JGL, Pantelis C. Clinical deficits correlate with regional cerebral atrophy in progressive supranuclear palsy. Brain. 2005; 128: 1259-1266.
13. Daniel SE, Bebruin VMS, Lees AJ. The clinical and pathological spectrum of Steele-Richardson-Olszewski syndrome (Progressive supranuclear palsy) - a reappraisal. Brain. 1995; 118: 759-770.
14. De Lacoste M, White CL. The role of cortical connectivity in Alzheimer's disease pathogenesis: a review and model system. Neurobiol Aging. 1993; 14: 1-16.
15. Dickson DW. Neuropathological differentiation of progressive supranuclear palsy and corticobasal degeneration. J Neurol. 1999; 246: 6-15.
16. Dickson DW. Neurodegeneration: The Molecular Pathology of Dementia and Movement Disorders. Basel: International Society for Neuropathology (ISN) Press; 2003.
17. Duyckaerts C, Hauw JJ, Bastenaire F, Piette F, Poulain C, Rainsard V, Javoy-Agid F, Berthaux P. Laminar distribution of neocortical senile plaques in senile dementia of the Alzheimer type. Acta Neuropathol. 1986; 70: 249-256.
18. Gomez-Haro C, Espert-Torbajada R, Gadea-Domenech M, Navarro-Humanes JF. Progressive supranuclear palsy: Neurological, neuropathological and neuropsychological aspects. Rev de Neurol. 1999; 29: 936-956.
19. Hattori M, Hashizume Y, Yoshida M, Iwasaki Y, Hishikawa N, Ueda R, Ojika K. Distribution of astrocytic plaques in corticobasal degeneration brain and comparison with tuft shaped astrocytes in the progressive supranuclear palsy brain. Acta Neuropathol. 2003; 106: 143-149.
20. Hauw JJ, Daniel SE, Dickson D, Horoupian DS, Jellinger K, Lantos PL, McKee A, Tabaton M, Litvan I. Preliminary NINDS neuropathologic criteria for Steele-Richardson-Olszewski syndrome (PSP). Neurology. 1994; 44: 2015-2019.
21. Higgins JJ, Adler RL, Loveless JM. Mutational analysis of the tau gene in progressive supranuclear palsy. Neurology. 1999; 53: 1421-1424.
22. Ikeda K, Akiyama H, Kondo H, Haga C, Tanno E, Tokuda T, Ikeda S. Thorn-shaped astrocytes: possibly secondarily induced tau-positive glial fibrillary tangles. Acta Neuropathol. 1995; 90: 620-625.
23. Komori T. Tau positive glial inclusions in progressive supranuclear palsy, corticobasal degeneration and Pick's disease. Brain Pathol. 1999; 9: 663-679.
24. Lantos PL. The neuropathology of progressive supranuclear palsy. J Neural Transm. (Suppl.) 1994; 42: 137-152.
25. Litvan I, Agid Y, Calne D, Campbell G, Dubois B, Davoisen RC, Goetz CG, Golbe LI, Grafman J, Growden JH, Hallett M, Jankovic J, Quinn NP, Tolisa E, Zee DS, Chase TW, FitzGibbon EJ, Hall Z, Juncos J, Nelson KB, Oliver E, Pramstaller P, Reich SG, Verny M. Clinical research criteria for the diagnosis of progressive supranuclear palsy (Steele-Richardson-Olszewski syndrome): report of the NINDS-SPSP International Workshop. Neurology. 1996a; 47: 1-9.
26. Litvan I, Hauw JJ, Bartko JJ, Lantos PL, Daniel SE, Horoupian DS, McKee A, Dickson D, Bancher C, Tabaton M, Jellinger K, Anderson DW. Validity and reliability of the preliminary NINDS neuropathological criteria for progressive supranuclear palsy and related disorders. J Neuropath Exp Neurol. 1996b; 55: 97-105.
27. Litvan I, Grimes DA, Lang AE, Jankovic J, McKee A, Verny M, Jellinger K, Chaudhuri KR, Pearce RKB. Clinical features differentiating patients with post-mortem confirmed progressive supranuclear palsy and corticobasal degeneration. J Neurol. 1999; 246: 1-5.
28. Mackenzie IRA, Hudson LP. Achromatic neurons in the cortex of progressive supranuclear palsy. Acta Neuropathol. 1995; 90: 615-619.
29. Montpetit V, Clapin DF, Guberman M. Substructure of 20 nm filaments of progressive supranuclear palsy. Acta Neuropathol. 1985; 68: 311-318.
30. Nath U, Ben-Shlomo Y, Thomson RG, Morris HR, Wood NW, Lees AJ, Burn DJ. The prevalence of progressive supranuclear palsy (Steele-Richardson-Olszewski syndrome) in the UK. Brain. 2001; 124: 1438-1449.
31. Papapetropoulos S, Gonzalez J, Mash DC. Natural history of progressive supranuclear palsy: a clinicopathologic study from a population of brain donors. Eur Neurol. 2005; 54: 1-9.
32. Sachin S, Kumaran SS, Singh S, Goyal V, Shukla G, Mahajan H, Behari M. Functional mapping in PD and PSP for sustained phonation and phoneme tasks. J Neurol Aci. 2008; 273: 51-56.
33. Schrag A, Ben-Shlomo Y, Quinn NP. Prevalence of progressive supranuclear palsy and multiple system atrophy: a cross-sectional study. Lancet. 1999; 354: 1771-1775.
34. Snedecor GW, Cochran WG. Statistical Methods. Ames: Iowa State University Press; 1980.
35. Stanford PM, Halliday GM, Brooks WS, Kwok JBJ, Storey CE, Creasey H, Morris JGL, Fulham MJ, Schofield PR. Progressive supranuclear palsy pathology caused by a novel silent mutation in exon 10 of the tau gene: expansion of the disease phenotype caused by the tau gene mutations. Brain. 2000; 123: 880-893.
36. Tellez-Nagel I, Wisniewski HM. Ultrastructure of neurofibrillary tangles in Steele-Richardson-Olszewski syndrome. Arch Neurol. 1973; 29: 324-327.
37. Williams DR, de Silva R, Paviour DC, Pittman A, Watt HC, Kilford L, Holton JL, Revesz T, Lees AJ. Characteristics of two distinct clinical phenotypes in pathologically proven progressive supranuclear palsy: Richardson's syndrome and PSP-parkinsonism. Brain. 2005; 128: 1247-1258.
38. Williams DR, Holton JL, Strand K, de Silva R, Lees AJ, Revesz T. Differences in tau load are associated with different clinical phenotypes in progressive supranuclear palsy. Neuropathol Appl Neurobiol. 2007; 33: 256-257.
39. Yamada T, McGeer PL, McGeer EG. Appearance of paired nucleated tau-positive glia in patients with progressive supranuclear palsy brain tissue. Neurosci Lett. 1992; 135: 99-102.